Literature DB >> 13106712

Western equine encephalitis in infants; a report on three cases with sequelae.

H B BRUYN, E H LENNETTE.   

Abstract

Approximately one-third of the laboratory-confirmed cases of Western equine encephalitis occur in children under the age of 10. The present paper describes three instances of Western equine encephalomyelitis virus infection in infants under one year of age, together with the resultant sequelae. The difficulties associated with diagnosis of central nervous system disturbances in very young children are discussed, and it is pointed out that in view of the frequent occurrence of clinical infections with the arthropod-borne encephalitis viruses these agents should be given serious consideration as a cause of acute central nervous system infection in childhood and as the possible etiology for obscure, severe neurological disturbances in the pediatric age groups.

Entities:  

Keywords:  ENCEPHALOMYELITIS, EQUINE/in infant and child

Mesh:

Year:  1953        PMID: 13106712      PMCID: PMC1521921     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  4 in total

1.  THE ETIOLOGY OF EPIZOOTIC ENCEPHALOMYELITIS OF HORSES IN THE SAN JOAQUIN VALLEY, 1930.

Authors:  K F Meyer; C M Haring; B Howitt
Journal:  Science       Date:  1931-08-28       Impact factor: 47.728

2.  Epidemiology of Epidemic Encephalitis in California.

Authors:  H L Wynns; C J Hawley
Journal:  Am J Public Health Nations Health       Date:  1939-07

3.  The Pathology of Japanese B Encephalitis.

Authors:  H M Zimmerman
Journal:  Am J Pathol       Date:  1946-09       Impact factor: 4.307

4.  Western equine and St. Louis encephalitis in man, California, 1945-1950.

Authors:  E H LENNETTE; W A LONGSHORE
Journal:  Calif Med       Date:  1951-09
  4 in total
  7 in total

1.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

2.  Interferon gamma modulation of disease manifestation and the local antibody response to alphavirus encephalomyelitis.

Authors:  Victoria K Baxter; Diane E Griffin
Journal:  J Gen Virol       Date:  2016-09-22       Impact factor: 3.891

3.  Neurological sequelae induced by alphavirus infection of the CNS are attenuated by treatment with the glutamine antagonist 6-diazo-5-oxo-l-norleucine.

Authors:  Michelle C Potter; Victoria K Baxter; Robert W Mathey; Jesse Alt; Camilo Rojas; Diane E Griffin; Barbara S Slusher
Journal:  J Neurovirol       Date:  2015-02-03       Impact factor: 3.739

4.  Mouse Model of Neurological Complications Resulting from Encephalitic Alphavirus Infection.

Authors:  Shannon E Ronca; Jeanon Smith; Takaaki Koma; Magda M Miller; Nadezhda Yun; Kelly T Dineley; Slobodan Paessler
Journal:  Front Microbiol       Date:  2017-02-07       Impact factor: 5.640

Review 5.  Genetic control of alphavirus pathogenesis.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Mamm Genome       Date:  2018-08-27       Impact factor: 2.957

6.  Glutamine antagonist-mediated immune suppression decreases pathology but delays virus clearance in mice during nonfatal alphavirus encephalomyelitis.

Authors:  Victoria K Baxter; Rebecca Glowinski; Alicia M Braxton; Michelle C Potter; Barbara S Slusher; Diane E Griffin
Journal:  Virology       Date:  2017-05-19       Impact factor: 3.513

7.  Both ADP-Ribosyl-Binding and Hydrolase Activities of the Alphavirus nsP3 Macrodomain Affect Neurovirulence in Mice.

Authors:  Rachy Abraham; Robert L McPherson; Morgan Dasovich; Mohsen Badiee; Anthony K L Leung; Diane E Griffin
Journal:  mBio       Date:  2020-02-11       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.